Latest News

Here you find the latest news revolving Sensidose.

Information regarding Navamedic’s public takeover offer

Information regarding Navamedic’s public takeover offer

Navamedic ASA ("Navamedic") announced on 29 March 2023 a public takeover offer to the shareholders of Sensidose Aktiebolag. Sensidose has published the following information relating to the takeover offer:     For further information, please see Navamedic's...

Sensidose granted reimbursement for Flexilev in Finland

As part of Sensidose's ongoing geographical expansion, the company last autumn applied for reimbursement for Flexilev with the Finnish Pharmaceutical Price Board (Lääkkeiden hintalautakunta). The application has now been granted and the approval is in accordance with...

Sensidose recruits Deputy CEO for the expansion

Pharma company Sensidose has recruited Philip Slätis as Chief Operating Officer and Deputy CEO. Slätis takes on on his role on November 1 and brings broad experience from the pharmaceutical industry. He is expected to contribute to the company’s business development...

Biostock: Continued positive sales development for Sensidose

Biostock: Continued positive sales development for Sensidose

Sensidose recently reported an increase in net sales of 21 per cent for the second quarter compared to the same period in 2021. At the same time as the company is growing, they have also made progress during the quarter in the development of the new dosing device,...